Anterix Inc. ATEX

Rank #2328 · Nasdaq · $1.8B market cap

Audited by DELOITTE & TOUCHE LLP, no going-concern flag in the latest filing.

Score

24.4

P/E

-155.5

P/B

10.98

ROE

-7.1%

Op. Margin

-194.2%

Debt Ratio

110%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Weak

P/E -155.5x, P/B 10.98x. Ranks in the top 74% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -7.1%. Ranks in the top 84% of the universe.

Safety ★★★☆☆

Average

Debt ratio 110%. Ranks in the top 43% of the universe.

Growth ★★★★★

Excellent

Revenue growth of 43.9% year over year. Ranks in the top 8% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2015	$0.0B	$-0.0B	$-0.0B	$-0.0B	-36.8	-259
2016	$0.0B	$-0.0B	$-0.0B	$-0.0B	-25.0	-442
2017	$0.0B	$-0.0B	$-0.0B	$-0.0B	-446.5	-282
2018	$0.0B	$-0.0B	$-0.0B	$0.2B	-618.8	8
2019	$0.0B	$-0.0B	$-0.0B	$0.3B	-684.8	5
2020	$0.0B	$-0.0B	$-0.0B	$0.2B	-657.6	8
2021	$0.0B	$-0.0B	$-0.0B	$0.2B	-2399.8	12
2022	$0.0B	$-0.0B	$-0.0B	$0.2B	-2399.8	22
2023	$0.0B	$-0.1B	$-0.1B	$0.2B	-5951.0	37
2024	$0.0B	$-0.0B	$-0.0B	$0.2B	-857.8	53
2025	$0.0B	$-0.0B	$-0.0B	$0.2B	-241.5	91
2026	$0.0B	$-0.0B	$-0.0B	$0.2B	-194.2	110